|

REGN9933 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Regeneron Pharmaceuticals1

Indications

  • Atrial Fibrillation (AF)1
  • Heart Disease1

Dothan, Alabama1 trial

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

SEC Clinical Research

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.